Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
GENELUX Corp
Report date September 12, 2024 · Filed September 13, 2024
Section 16 reporting ended · disclosed 2024-09-13. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 632,901 |
Reported balance
After 2024-09-12 transaction · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · 2024-09-12 · Sale · Disposed 31,777 · Balance 632,901 F1: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $2.65 to $2.85, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. F2: Shares held by The Szalay 2010 Retained Annuity Trust. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 599,821 |
Reported balance
After 2024-09-13 transaction · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · 2024-09-13 · Sale · Disposed 33,080 · Balance 599,821 F3: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $2.35 to $2.80, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. F2: Shares held by The Szalay 2010 Retained Annuity Trust. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 2,258,760 |
Reported balance
Holding disclosure · report date 2024-09-12 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 2,258,760 F4: Shares held by The Szalay 2009 Irrevocable Trust. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 550,000 |
Reported balance
Holding disclosure · report date 2024-09-12 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 550,000 F5: Shares held by The Szalay 2010 Children's Trust. |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 5,000 |
Reported balance
Holding disclosure · report date 2024-09-12 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 5,000 |
Filing footnotes · ownership attribution and instrument terms
F1: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $2.65 to $2.85, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
F2: Shares held by The Szalay 2010 Retained Annuity Trust.
F3: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $2.35 to $2.80, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
F4: Shares held by The Szalay 2009 Irrevocable Trust.
F5: Shares held by The Szalay 2010 Children's Trust.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 12, 2023 Filed Sep 13, 2023 23:04 UTC | GENELUX Corp GNLX · Entity 1116 | SaleCommon Stock | 13,727 | $22.51 | $308,935.74 |
DisclosureSEC source: 0001209191-23-049349 · doc4.xml · nonDerivative · entry 4 Szalay Aladar · CIK 0001937513 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 79,600 F4 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $22.14 to $23.01, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| September 12, 2023 Filed Sep 13, 2023 23:04 UTC | GENELUX Corp GNLX · Entity 1116 | SaleCommon Stock | 6,538 | $21.75 | $142,230.92 |
DisclosureSEC source: 0001209191-23-049349 · doc4.xml · nonDerivative · entry 3 Szalay Aladar · CIK 0001937513 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 93,327 F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $21.1405 to $22.1245, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| September 11, 2023 Filed Sep 13, 2023 23:04 UTC | GENELUX Corp GNLX · Entity 1116 | SaleCommon Stock | 23,020 | $22.55 | $519,156.25 |
DisclosureSEC source: 0001209191-23-049349 · doc4.xml · nonDerivative · entry 2 Szalay Aladar · CIK 0001937513 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 99,865 F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $22.02 to $22.84, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| September 11, 2023 Filed Sep 13, 2023 23:04 UTC | GENELUX Corp GNLX · Entity 1116 | SaleCommon Stock | 9,331 | $21.39 | $199,545.30 |
DisclosureSEC source: 0001209191-23-049349 · doc4.xml · nonDerivative · entry 1 Szalay Aladar · CIK 0001937513 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 122,885 F1 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.92, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| September 08, 2023 Filed Sep 11, 2023 23:05 UTC | GENELUX Corp GNLX · Entity 1116 | SaleCommon Stock | 2,636 | $24.19 | $63,752.19 |
DisclosureSEC source: 0001209191-23-049013 · doc4.xml · nonDerivative · entry 5 Szalay Aladar · CIK 0001937513 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 132,216 F6 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $24.165 to $24.205, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| September 08, 2023 Filed Sep 11, 2023 23:05 UTC | GENELUX Corp GNLX · Entity 1116 | SaleCommon Stock | 8,523 | $23.49 | $200,168.62 |
DisclosureSEC source: 0001209191-23-049013 · doc4.xml · nonDerivative · entry 4 Szalay Aladar · CIK 0001937513 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 134,852 F5 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $23.16 to $24.155, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| September 08, 2023 Filed Sep 11, 2023 23:05 UTC | GENELUX Corp GNLX · Entity 1116 | SaleCommon Stock | 13,672 | $22.78 | $311,411.25 |
DisclosureSEC source: 0001209191-23-049013 · doc4.xml · nonDerivative · entry 3 Szalay Aladar · CIK 0001937513 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 143,375 F4 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $22.16 to $23.1561, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| September 07, 2023 Filed Sep 11, 2023 23:05 UTC | GENELUX Corp GNLX · Entity 1116 | SaleCommon Stock | 2,508 | $25.34 | $63,551.47 |
DisclosureSEC source: 0001209191-23-049013 · doc4.xml · nonDerivative · entry 2 Szalay Aladar · CIK 0001937513 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 157,047 F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $25.03 to $25.55, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| September 07, 2023 Filed Sep 11, 2023 23:05 UTC | GENELUX Corp GNLX · Entity 1116 | SaleCommon Stock | 9,938 | $24.12 | $239,716.49 |
DisclosureSEC source: 0001209191-23-049013 · doc4.xml · nonDerivative · entry 1 Szalay Aladar · CIK 0001937513 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 159,555 F1 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $23.79 to $24.55, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. F2 · balance_after: The Form 3 filed by the reporting person on January 25, 2023 and the Form 4 filed by the reporting person on January 30, 2023 inadvertently overstated the amount of securities beneficially owned by one share. Read SEC document |
| January 30, 2023 Filed Jan 30, 2023 21:29 UTC | GENELUX Corp GNLX · Entity 1116 | ConversionSeries A Preferred Stock · Derivative | 1,500,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-005480 · doc4.xml · derivative · entry 7 Szalay Aladar · CIK 0001937513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 0 Underlying: Common Stock · 500,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock automatically converted into shares of Common Stock at a conversion ratio of 1 share of Common Stock for each 3 shares of Preferred Stock upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date. F1 · price: Each share of Series A Preferred Stock automatically converted into shares of Common Stock at a conversion ratio of 1 share of Common Stock for each 3 shares of Preferred Stock upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock automatically converted into shares of Common Stock at a conversion ratio of 1 share of Common Stock for each 3 shares of Preferred Stock upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock automatically converted into shares of Common Stock at a conversion ratio of 1 share of Common Stock for each 3 shares of Preferred Stock upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date. F3 · ownership.nature: Shares held by The Szalay Children's Trust. Read SEC document |
| January 30, 2023 Filed Jan 30, 2023 21:29 UTC | GENELUX Corp GNLX · Entity 1116 | ConversionSeries A Preferred Stock · Derivative | 1,500,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-005480 · doc4.xml · derivative · entry 6 Szalay Aladar · CIK 0001937513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 0 Underlying: Common Stock · 500,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock automatically converted into shares of Common Stock at a conversion ratio of 1 share of Common Stock for each 3 shares of Preferred Stock upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date. F1 · price: Each share of Series A Preferred Stock automatically converted into shares of Common Stock at a conversion ratio of 1 share of Common Stock for each 3 shares of Preferred Stock upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock automatically converted into shares of Common Stock at a conversion ratio of 1 share of Common Stock for each 3 shares of Preferred Stock upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock automatically converted into shares of Common Stock at a conversion ratio of 1 share of Common Stock for each 3 shares of Preferred Stock upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date. F2 · ownership.nature: Shares held by The Szalay 2009 Irrevocable Trust. Read SEC document |
| January 30, 2023 Filed Jan 30, 2023 21:29 UTC | GENELUX Corp GNLX · Entity 1116 | ConversionCommon Stock | 500,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-005480 · doc4.xml · nonDerivative · entry 2 Szalay Aladar · CIK 0001937513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 550,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A Preferred Stock automatically converted into shares of Common Stock at a conversion ratio of 1 share of Common Stock for each 3 shares of Preferred Stock upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date. F3 · ownership.nature: Shares held by The Szalay Children's Trust. Read SEC document |
| January 30, 2023 Filed Jan 30, 2023 21:29 UTC | GENELUX Corp GNLX · Entity 1116 | ConversionCommon Stock | 500,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-005480 · doc4.xml · nonDerivative · entry 1 Szalay Aladar · CIK 0001937513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 2,258,760 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A Preferred Stock automatically converted into shares of Common Stock at a conversion ratio of 1 share of Common Stock for each 3 shares of Preferred Stock upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date. F2 · ownership.nature: Shares held by The Szalay 2009 Irrevocable Trust. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.